|
|
|
|
Ashcraft & Gerel
LLP
|
|
|
|
Studies Confirm Trasylol Causes Increased Risk of Death & Kidney Damage - "60 Minutes" Television Show Airs Segment on Trasylol
On February 21, two studies were published in the New England Journal of Medicine concerning the drug Trasylol (aprotonin). Both studies confirm that Trasylol causes an increased risk of death and kidney damage compared to alternative medicines, or no medicine at all. The first looked at approximately 10,000 patients who had bypasses at Duke University Medical Center from 1996 through 2005. It found that 6.4 percent of patients who were given Trasylol died within 30 days of the surgery, a rate nearly 2.5 times higher than patients who recevied another drug or who received no treatment for bleeding. The second study, financed by Bayer--the manufacturer of Trasylol--looked at approximately 78,000 patients nationwide from 2003 to 2006. After adjusting for other factors, the researchers found the risk of death was 64 percent higher in the Trasylol group than in those taking a comparison drug. Interestingly, this study was eventually presented to FDA regulators last year after Bayer initially withheld it at a September 2006 FDA Advisory Committee Meeting.
Two alternatives medicines exist - aminocaproic acid and tranexamic acid - both of which are substantially less expensive than Trasylol. According to the two most recent articles and Dr. Dennis Mangano's original study that cast doubt on the safety of Trasylol, aminocaproic acid and tranexamic acid are equally effective in reducing the risk of needing blood transfusions due to blood loss and present none of the health risks associated with Trasylol.
According to the above report on 60 Minutes, which aired on February 17, 2008, the delay in taking Trasylol off the market after the publication of Dr. Mangano's groundbreaking study may have cost 22,000 lives. Dr. Mangano estimated in the report that as many as 1,000 people per month died as a result of the use of Trayslol during Coronary Artery Bypass Graft surgeries from the date of publication of his article in January, 2006 until the drug's eventual withdrawal in November of 2007.
If you think you or a loved one may have suffered an injury or damages as a result of receiving Trasylol during a cardiac bypass, CABG, procedure, you owe it to yourself to speak to an experienced pharmaceutical attorney to see if you have a case and to discuss the possibility of bringing a lawsuit to recover for your damages and injuries. The attorney will be able to ascertain if you have a claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award or other recovery, and the experienced lawyer will be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft and Gerel, LLP to discuss your case with an experienced drug or pharmaceutical lawyer in our Drug Litigation Department.
The lawyers at Ashcraft and Gerel, LLP have been leaders in pursuing lawsuits involving unsafe drugs, implants, and infusions. Our attorneys have successfully brought about verdicts, settlements, awards or other recoveries in lawsuits on behalf of clients who have been injured by Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA), Baycol, breast implants and AIDS tainted blood.
Although some of these lawsuits resulted in class action settlements, class
actions are not the only way these cases are handled. The courts have devised
methods to deal with mass torts so that each lawsuit can benefit from
information and evidence gathered in other lawsuits nationwide and yet be
handled on an individual basis.
We have a toll free number to reach an attorney to answer your questions with regard to your specific case. That number is 1-800-829-7037. Please ask to speak to Robert Samet, and he will place you in touch with one of our drug litigation lawyers. If you would prefer, please feel free to
e-mail us or complete the
help inquiry form on this web site. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our lawyer can provide you with the specific information you seek.
[ Return to Homepage ] [ Help ] [ Learn About Ashcraft & Gerel ] [ See Our Offices and Attorneys ] [ Email Us ] [ Links ] [Resources] [AG Friends & Associates] [ Contingent Fees in Personal Injury Litigation ] [ Workers' Compensation ] [Maryland Workers' Compensation] [District of Columbia Workers' Compensation] [Virginia Workers' Compensation] [ Product Liability Law ] [ Cerebral Palsy ] [ Medical Malpractice ] [ Automobile Accident Litigation ] [Maryland, Virginia and D.C. Injuries and Accidents] [ Birth Injury Litigation ] [ Social Security Disability ] [ Fen Phen Litigation ] [ Asbestos Litigation ] [ Toxic Tort Litigation ] [ Breast Implant Litigation ] [ Whistle Blower Litigation ] [ Construction Litigation ] [ Railroad Worker (FELA) Litigation ] [ Propulsid Litigation ] [ PPA Litigation ] [ Nursing Home Malpractice ] [ Sulzer Defective Hip Implants ] [ Defense Base Act Claims ] [ Baycol Claims ] [ Other Hip Implant Claims ] [ Thimerosal Mercury Poisoning Autism Claims ] [ Olympus Bronchoscope Claims ] [ Serzone Liver Damage Claims ] [Ephedra Claims] [Crestor Claims] [ Meridia Claims ] [ Lead Paint Claims ] [ Vioxx Claims ] [Celebrex Claims] [Bextra Claims] [Ortho Evra Claims]
